<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Xu F</submitter><pubmed_abstract>The subject of the study is an 11-month old IVF baby girl with the typical clinical manifestation of malonyl coenzyme A decarboxylase deficiency, including developmental delay, limb weakness, cardiomyopathy, and excessive excretion of malonic acid and methylmalonic acid. Whole genome sequencing (WGS) revealed a novel heterozygous nonsense mutation (c.672delG, p.Trp224Ter) in the MLYCD gene of the proband and her father and a novel heterozygous deletion in 5'-UTR-exon1-intron1 of the MLYCD gene of the proband and her mother. The patient's cardiac function and limb weakness improved considerably after 3 months of a low-fat diet supplemented with L-carnitine. Furthermore, mapping of gene mutations and clinical manifestations was done by case collection.</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>1160879</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10189016</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Case report: A novel 5'-UTR-exon1-intron1 deletion in MLYCD in an IVF child with malonyl coenzyme A decarboxylase deficiency and literature review.</pubmed_title><pmcid>PMC10189016</pmcid><pubmed_authors>Duan J</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Xu F</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Case report: A novel 5'-UTR-exon1-intron1 deletion in MLYCD in an IVF child with malonyl coenzyme A decarboxylase deficiency and literature review.</name><description>The subject of the study is an 11-month old IVF baby girl with the typical clinical manifestation of malonyl coenzyme A decarboxylase deficiency, including developmental delay, limb weakness, cardiomyopathy, and excessive excretion of malonic acid and methylmalonic acid. Whole genome sequencing (WGS) revealed a novel heterozygous nonsense mutation (c.672delG, p.Trp224Ter) in the MLYCD gene of the proband and her father and a novel heterozygous deletion in 5'-UTR-exon1-intron1 of the MLYCD gene of the proband and her mother. The patient's cardiac function and limb weakness improved considerably after 3 months of a low-fat diet supplemented with L-carnitine. Furthermore, mapping of gene mutations and clinical manifestations was done by case collection.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-04-08T13:23:23.568Z</modification><creation>2025-02-19T04:55:14.575Z</creation></dates><accession>S-EPMC10189016</accession><cross_references><pubmed>37206471</pubmed><doi>10.3389/fmed.2023.1160879</doi></cross_references></HashMap>